1. Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial. Issue 7 (July 2020) Authors: Koch, Till; Dahlke, Christine; Fathi, Anahita; Kupke, Alexandra; Krähling, Verena; Okba, Nisreen M A; Halwe, Sandro; Rohde, Cornelius; Eickmann, Markus; Volz, Asisa; Hesterkamp, Thomas; Jambrecina, Alen; Borregaard, Saskia; Ly, My L; Zinser, Madeleine E; Bartels, Etienne; Poetsch, Joseph S H; Neu... Journal: Lancet infectious diseases Issue: Volume 20:Issue 7(2020) Page Start: 827 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗